Presentation

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Presenter: Charles V. Pollack Jr

June 24, 2015

REGISTER for free or LOG IN to view this content

RE-VERSE AD: Idarucizumab for Dabigatran Reversal

Coronary

CAD Pharma

Factoid

Up Next

Presentation

Sex Differences in Rate, Timing, and Diagnoses of 30-Day Readmissions in Younger Pts With Acute MI

Presenter: Rachel P. Dreyer

June 25, 2015

More slides +

Presentation

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Presenter: Kenneth Rosenfield

June 25, 2015

Presentation

Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI

Presenter: J. Parsh

June 26, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.